Amgen said there is no link between its experimental weight loss drug, MariTide, and changes in bone density. The ...
Amgen addresses safety concerns for its weight loss drug MariTide after new data suggests a potential 4% reduction in bone ...
HEALTH LITERACY: Understanding osteoporosis: Causes, risk factors, and preventive strategies for bone health ...
Analysts cited data from a phase one study showing the highest dose of Amgen’s MariTide was linked to roughly 4% loss of bone ...
Lung transplant patients should undergo annual bone health screenings using dual-energy X-ray absorptiometry for the first ...
Why are postmenopausal women more susceptible to bone issues? “Bone density peaks at around 35 years old then naturally decreases with age,” explains Dr Thom Phillips, NHS GP and clinical lead ...
Investigators used 3-dimensional quantitative computed tomography to more accurately assess patients’ bone mineral ...
Research indicates that vitamin D supplementation during pregnancy positively impacts children's bone health and lean mass, ...
(Reuters) -Amgen said on Wednesday there was no link between its experimental weight-loss drug and changes in bone ...
Amgen Inc.‘s AMGN stock dropped over 7% on Tuesday following revelations about bone density loss in early trials of its ...